ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs MXN
20.6314
0.01%
Brent Oil
76.495
0.00%
Bitcoin
98,323.30
0.22%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Medicenna Therapeutics Corporation (MDNA) Cotización

Medicenna Therapeutics Corporation

Medicenna Therapeutics Corporation (MDNA)

Medicenna Therapeutics Corp
0.157
0.00
(0.00%)
Cerrado 04 Enero 3:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
Fuera de horario: -
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
0.157
Postura de Compra
0.1565
Postura de Venta
0.1612
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
10.933M
Precio Anterior
0.157
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
69,637,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-4.35
Beneficio por acción (BPA)
-0.37
turnover
-
Beneficio neto
-25.47M

Acerca de Medicenna Therapeutics Corporation

Medicenna Therapeutics Corp is a Canada based immuno-oncology company. Its principal business activity is the development and commercialization of Empowered Cytokines and Superkines for the treatment of cancer. The company is engaged in developing Interleukin-4 Empowered Cytokines that specifically ... Medicenna Therapeutics Corp is a Canada based immuno-oncology company. Its principal business activity is the development and commercialization of Empowered Cytokines and Superkines for the treatment of cancer. The company is engaged in developing Interleukin-4 Empowered Cytokines that specifically target the Interleukin-4 Receptor which is over-expressed by 20 different cancers, cancer stem cells and immunosuppressive cells of the tumor microenvironment. The have the potential to purge the tumor and un-blind the immune system to cancer thereby altering the treatment paradigm for a large majority of cancer patients. Mostrar más

Sector
Biological Pds,ex Diagnstics
Industria
Biological Pds,ex Diagnstics
Sitio web
www.medicenna.com
Sede
Toronto, Ontario, Can
Fundado
-

MDNA Últimas noticias

Más noticias

Form 15-12G - Securities registration termination [Section 12(g)]

14 Mayo 2024
Edgar (US Regulatory)

Form D - Notice of Exempt Offering of Securities

14 Mayo 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

13 Mayo 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

30 Abril 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

26 Abril 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

25 Abril 2024
Edgar (US Regulatory)

Form AW - Amendment Withdrawal Request

22 Abril 2024
Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

16 Abril 2024
Edgar (US Regulatory)

Form F-3/A - Registration statement by foreign private issuers: [Amend]

16 Abril 2024
Edgar (US Regulatory)

Form F-10POS - Post-effective amendment to a F-10EF registration

16 Abril 2024
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

MDNA - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Medicenna Therapeutics?
El precio actual de las acciones de Medicenna Therapeutics es US$ 0.157
¿Cuántas acciones de Medicenna Therapeutics están en circulación?
Medicenna Therapeutics tiene 69,637,000 acciones en circulación
¿Cuál es la capitalización de mercado de Medicenna Therapeutics?
La capitalización de mercado de Medicenna Therapeutics es USD 10.93M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Medicenna Therapeutics?
Medicenna Therapeutics ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Medicenna Therapeutics?
El ratio precio/beneficio de Medicenna Therapeutics es -4.35
¿Cuál es la moneda de reporte de Medicenna Therapeutics?
Medicenna Therapeutics presenta sus resultados financieros en CAD
¿Cuál es el último beneficio anual de Medicenna Therapeutics?
El último beneficio anual de Medicenna Therapeutics es CAD -25.47M
¿Cuál es la dirección registrada de Medicenna Therapeutics?
La dirección registrada de Medicenna Therapeutics es 200 - 1920 YONGE STREET, TORONTO, ONTARIO, M4S 3E2
¿Cuál es la dirección del sitio web de Medicenna Therapeutics?
La dirección del sitio web de Medicenna Therapeutics es www.medicenna.com
¿En qué sector industrial opera Medicenna Therapeutics?
Medicenna Therapeutics opera en el sector BIOLOGICAL PDS,EX DIAGNSTICS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
259.78M
NITON2OFF Inc
US$ 2.6306
(145.85%)
350.92M
CRNCCerence Inc
US$ 19.33
(143.76%)
159.55M
KITTNauticus Robotics Inc
US$ 3.8249
(140.56%)
104.78M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.59M
HWHHWH International Inc
US$ 0.4621
(-28.80%)
7.43M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5.69
(-26.30%)
24.77M
RAINRain Enhancement Technologies Holdco Inc
US$ 5.59
(-23.42%)
161.15k
PTLEPTL Ltd
US$ 9.35
(-23.30%)
1.04M
NXUNXU Inc
US$ 0.725868
(-22.78%)
7.59M
NITON2OFF Inc
US$ 2.6306
(145.85%)
350.92M
TGLTreasure Global Inc
US$ 0.382
(101.58%)
330.82M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.59M
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
259.78M
NVDANVIDIA Corporation
US$ 144.47
(4.45%)
222.72M

Discusión

Ver feed completo
AtlasQ AtlasQ 58 segundos hace
Glad to see some of these targets. Billionaires in the making 
RDGL
TenKay TenKay 1 minuto hace
Unfortunately no….but I do have a wicked Blue Steel pose.
HMBL
Prestotic Prestotic 1 minuto hace
Maybe Virexit will get contracts to install Maxclean in Microsofts new data centers in 2025. Imagine, a small cut of 80 billion $. That would be so much better that NO revenue....NO contracts.... yet someone keeps scooping up all the 4's they can get there hands on...
VXIT
HGilS HGilS 1 minuto hace
Hi kayak

I don’t want to start a polemic here this is not the place.

Israel did not send ANY missile on Gaza. Missiles are blind and can hit civilian population.

Bombs were sent after informing civilian population about bombings about to happen.
ELTP
Pittkid Pittkid 2 minutos hace
One of the primary critics on a popular stock forum had consistently targeted the stocks listed below until HUMBL experienced an increase in value in December. Do you notice what all his targeted stocks have in common? A simple review of his posting history provides clear evidence of his interests.
HMBL
ziploc_1 ziploc_1 2 minutos hace
For significant increases in stock price, Amarin needs significant increases in earnings from the U.S...

Patented Lr Et EPA could be a way to produce those earnings.

With the previous success of the Reduce-It study, i.e.as to the safety and efficacy of the EPA drug, Va
AMRN
dstock07734 dstock07734 3 minutos hace
Have you figured out why Merck ran expansion cohort on the neoadjuvant therapy on rGBM patients while the combo trial was undergoing? Any idea why Dr. Liau was not among the coauthors while the rest of her team were listed?

I can see that Merck was very careful and in the data analys
NWBO
fuagf fuagf 3 minutos hace
Yep, bottom line: [...]Related: Musk projects his hard-right influence in Europe
The ever-more powerful Tesla and SpaceX chief is turning his gaze on Europe, where many governments are already grappling with the rise of populism and the far-right.
[...]Musk's political initiatives are
dennisdave dennisdave 3 minutos hace
Saying getting somebody to agree to run what is basically an ATM for them is some sort of huge deal is funny.
NWBO should have initiated an at-the-market (ATM) selling of shares to finance operations years ago as dozens of non revenue biotechs have done.

I still cannot for th
NWBO
doomed doomed 3 minutos hace
We have a bunch of cannabis naive expert on this board…
They seem to know what they are doing…😂
Fools rush in, where wiseman never go…
TLRY
MrMike241 MrMike241 4 minutos hace
Ask about Tri Cascade and the GX500G 5G modem at the Quectel booth. Show them the Quectel PR if necessary. The folks running the booth might not know more than they are there to demonstrate, but it could be interesting 🤔

https://www.quectel.com/customer-stories/iot-5g-modem-rg
SRMX
Jack_Herer Jack_Herer 6 minutos hace
You're not Derek Zoolander?

https://investorshub.advfn.com/uimage/uploads/2021/12/6/bkymec700x420.jpg
HMBL
doomed doomed 6 minutos hace
Tell us what is your favorite Tilray’s bunk strain?
You seem to know them well…😂
TLRY
Chromosome Chromosome 7 minutos hace
Speaking of France does anyone have any information on timing in 2025 other than “sometime in 2025” for reimbursement. I have not been able to find anything in their filings. TIA.
AMRN
Perk_Idaho Perk_Idaho 7 minutos hace
Make that 3.
NWBO
12yearplan 12yearplan 7 minutos hace
Yep, human organizations suck even with the facts of reality staring in the face.
The lobby was successful - so much so, now.. no country rights and genocidal program.
Two top Prezes in my world Carter and Obama (only time as Newmed alluded I'd consider moving to golf mecca Myrtle Beac
Konaploinks Konaploinks 7 minutos hace
Notice how ChatGPT isn’t aware of the fact that Ionq is also heavily into quantum networking and has their own Ionq Quantum OS. Quantum LLM’s and ML along with their Quantum hybrid suite. Sam needs to catch up and Margaret needs to get the word out to him more often.
Keep your eye on IonQ .
IONQ
Loudanepro Loudanepro 8 minutos hace
Look at the chart
TTCM
doomed doomed 8 minutos hace
Or get your Tilray bunk weed…
They are fucked!
Red is the colour that my baby wore…
TLRY
misterfishman misterfishman 9 minutos hace
Not all at once numnuts and you know this maasan.
NNRX
KuriousGeorge KuriousGeorge 10 minutos hace
Hi I just checked out Note 7 and noticed Note 5 re line of credit/promissory note. Is this wiped too?
TWOH
Golden Cross Golden Cross 10 minutos hace
$ILLR MR. WING FAI NG On Triller Share Price And The Importance Of Shareholder Value
https://youtube.com/watch?v=3Aw9CDqNHew
ILLR

Su Consulta Reciente

NASDAQ
MDNA
Medicenna Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados